Aytu BioPharma Inc
AYTU
Get informed when a big investor buys or sells
+ FollowMarket Cap$18.55M
Close$
$-1.88
189.7% downside
Current Fair Value
189.7% downsideOvervalued by 189.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $18.55 Million |
|---|---|
| Enterprise Value | $4.16 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.16 |
| Beta | 0.28 |
| Outstanding Shares | 10,511,583 |
Return
| Return on Equity | -96.90% |
|---|---|
| Return on Assets | -30.49% |
| Return on Invested Capital | -48.94% |
Valuation & Multiples
| P/E Ratio | -0.71 |
|---|---|
| PEG | 0.29 |
| Price to Sales | 0.42 |
| Price to Book Ratio | 0.7 |
| Enterprise Value to Revenue | 0.07 |
| Enterprise Value to EBIT | -0.16 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 2.96 |
| Debt to Equity | 0.35 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 18, 2026
EPS Estimate
$-0.50
Average shareholder expectationRevenue Estimate
$13.29 M
Average shareholder expectationNext Earnings Call
Expected Date
September 22, 2026
EPS Estimate
$-0.18
Average shareholder expectationRevenue Estimate
$17.18 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 39.38%▲ 1.81% |
|---|---|
| Total Invested | $14.64M▲ 49.35% |
| Investors Holding | 34▼ 3.00% |
ESG Score
No data
About Aytu BioPharma Inc
75 employees